Profile: Akers Biosciences Inc (AKR.L)

AKR.L on London Stock Exchange

277.50GBp
28 May 2015
Change (% chg)

0.00p (+0.00%)
Prev Close
277.50p
Open
277.50p
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,017
52-wk High
330.00p
52-wk Low
195.00p

Search Stocks

Akers Biosciences, Inc. (ABI) is a United States-based company. The Company is a designer and manufacturer of rapid diagnostic screening and testing products. The Company’s products include BreathScan, BreathScan PRO, CHUBE, METRON, PIFA Heparin/PF4, PIFA PLUSS PF4, Tri-Cholesterol and VIVO. The Company’s objective is to apply the flexible platforms to the development of rapid tests which fulfill unmet needs in a variety of fields, including cardiology/emergency medicine, infectious disease, metabolism/nutrition, neuropsychiatry and oncology, as well as on and off the job alcohol safety.

Company Address

Akers Biosciences Inc

201 Grove Rd
WEST DEPTFORD   NJ   08086-2231
P: +1856.8488698

Company Web Links

Search Stocks